▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Komodo Health Launches National Drug Projections to Deliver Real-Time Intelligence on Prescription Trends and Market Share

Healthcare technology company Komodo Health today launches a new product, National Drug Projections, bringing its customers a clear, complete, and detailed view of how many prescriptions are filled ac...

Business Wire

New Offering Unlocks Projected Insights into Pharmacy and Medical Benefit Drugs to Optimize Forecasts, Track Market Shifts, and Enhance Decision-Making Across 10,000+ Therapies

SAN FRANCISCO: Healthcare technology company Komodo Health today launches a new product, National Drug Projections, bringing its customers a clear, complete, and detailed view of how many prescriptions are filled across the country for any group of medications. The new solution unlocks real-time market landscape intelligence, such as prescription volume, units dispensed, and new patient starts, to deliver an in-depth understanding of treatment dynamics that can better inform revenue forecasts, market share tracking, marketing resourcing, salesforce sizing, and more.

For healthcare and Life Sciences teams, having a clear view of a company’s drug portfolio performance and future potential is essential to drive impactful brand strategies. Komodo’s new offering leverages a vast array of de-identified insights from the Healthcare Map™ – which is derived from Medicare claims, commercial claims, and health records from over 300 million individuals – to deliver a superior approach to answering important questions around measuring traditional prescription retail dispenses and tracking medical benefit infusions and procedures, prescription specialty products, and compound events.

National Drug Projections is the most comprehensive solution on the market, offering a view of both pharmacy benefit (retail and specialty) and medical benefit drugs – with brands, biosimilars, and generics grouped together or broken out – to swiftly compare medications side-by-side and identify opportunities in the market. With intelligence on more than 10,000 therapies, National Drug Projections allows users to build customized reports on drug trends and market share. Each report provides a transparent view of total projected vs. observed values, as well as confidence intervals.

“National Drug Projections delivers actionable intelligence and a precise view on market dynamics to help Life Sciences companies make smarter decisions,” said Paul Gurney, Senior Vice President of Data Product, Komodo Health. “With robust and up-to-date projections, companies can track competitive performance, proactively adjust their strategies, optimize resource allocation, and better navigate market uncertainties – ultimately helping maximize market share and drive growth in a fast-evolving landscape.”

Komodo’s new offering was designed to complement its Healthcare Map – the industry’s most robust and precise view of longitudinal de-identified patient-level insights – with access to projected variables that can help companies more accurately assess therapy volumes, track competitive landscapes in real-time, and develop reliable forecasts for market success.

National Drug Projections is available as a standalone product and can be integrated into Komodo’s MapLab platform, making it easily accessible across teams and functions. Users with any level of data expertise can select their drugs of interest and within minutes receive insights in a real time dashboard with multiple variables and visualizations. The new solution is the foundation for an evolving product suite, including future IC-grade, subnational, and indication-based projections, that Komodo Health will be launching over the coming months and into 2025.

About Komodo Health
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with artificial intelligence to connect the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo helps its customers unearth patient-centric insights at scale – marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision-making, close gaps in care, address disease burden, and help enterprises create a more cost-effective, value-driven healthcare system. For more information, visit Komodohealth.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Dronus gets a strategic investment by Eni Next

Eni's VC company invest in the Italian drone company to develop new solutions for industrial plants monitoring

Technology Reply wins the 2024 Oracle Partner Awards - Europe South Innovation

Oracle recognizes Technology Reply’s ability to develop and deliver pioneering solutions through partnering with Oracle

Most read

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

The Wright Way Enterprises Launches New Website, Celebrates First of Three…

The Wright Way Enterprises (TWW), a burgeoning leader in cybersecurity and consulting services, is thrilled to announce the launch of its newly redesigned…

Harvest Group Acquires Bold Strategies, Inc., Expanding Media and Shopper…

#acquisition--Harvest Group, a national integrated commerce agency, today announced its acquisition of Bold Strategies, Inc. (BOLD), an eCommerce, shopper…

Mr. Cooper Completes Acquisition of Flagstar’s Mortgage Operations

Mr. Cooper Group Inc. (“Mr. Cooper”) announced today that it has closed the previously announced acquisition of Flagstar Bank N.A. (“Flagstar”)’s mortgage…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!